Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > More like Pumper should wear pampers to catch the
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(328)
•••
Comment by Golddetectoron Nov 28, 2021 1:34pm
161 Views
Post# 34173680

RE:RE:RE:RE:More like Pumper should wear pampers to catch the

RE:RE:RE:RE:More like Pumper should wear pampers to catch the You are wasting your time talking sense to clowns. Their target was to bring it to 20cents for loading and that been achieved. Tbp q4 is finishing this week and we Unfortunately didn't have QIXLEEF interim reports planned in q3 yet it is are delayed and Reduvo approval expected q4 also pushed to q1. So we have QIXLEEF interims and Reduvo expected q3 and q4 are late already and we are into q1 next week. Sp is way oversold with mc below 80 millions for a drug at phase II trial which really stupid cheap. It is their best days to cover and load up so don't except them to slow down. They will keep these worthless posts and it will get only more aggressive. Holding strong for me with every and I'm very positive that ppl bashing here loading at these levels 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities